141 related articles for article (PubMed ID: 38052236)
1. Effects of reminiscence therapy on cognition, agitation, and quality of life in older adults with dementia receiving long-term care.
Bayram S
Psychogeriatrics; 2024 Mar; 24(2):155-164. PubMed ID: 38052236
[TBL] [Abstract][Full Text] [Related]
2. Reminiscence therapy for dementia.
Woods B; O'Philbin L; Farrell EM; Spector AE; Orrell M
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD001120. PubMed ID: 29493789
[TBL] [Abstract][Full Text] [Related]
3. Multicenter randomized controlled trial of the effects of individual reminiscence therapy on cognition, depression and quality of life: Analysis of a sample of older adults with Alzheimer's disease and vascular dementia.
Pérez-Sáez E; Justo-Henriques SI; Alves Apóstolo JL
Clin Neuropsychol; 2022 Oct; 36(7):1975-1996. PubMed ID: 33467972
[No Abstract] [Full Text] [Related]
4. A systematic review of the clinical effectiveness and cost-effectiveness of sensory, psychological and behavioural interventions for managing agitation in older adults with dementia.
Livingston G; Kelly L; Lewis-Holmes E; Baio G; Morris S; Patel N; Omar RZ; Katona C; Cooper C
Health Technol Assess; 2014 Jun; 18(39):1-226, v-vi. PubMed ID: 24947468
[TBL] [Abstract][Full Text] [Related]
5. The effect of reminiscence therapy on cognitive functions, depression, and quality of life in Alzheimer patients: Randomized controlled trial.
Lök N; Bademli K; Selçuk-Tosun A
Int J Geriatr Psychiatry; 2019 Jan; 34(1):47-53. PubMed ID: 30246408
[TBL] [Abstract][Full Text] [Related]
6. Impact of person-centred care training and person-centred activities on quality of life, agitation, and antipsychotic use in people with dementia living in nursing homes: A cluster-randomised controlled trial.
Ballard C; Corbett A; Orrell M; Williams G; Moniz-Cook E; Romeo R; Woods B; Garrod L; Testad I; Woodward-Carlton B; Wenborn J; Knapp M; Fossey J
PLoS Med; 2018 Feb; 15(2):e1002500. PubMed ID: 29408901
[TBL] [Abstract][Full Text] [Related]
7. A pragmatic, multicentre, double-blind, placebo-controlled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer's disease and agitated behaviours: the HTA-SYMBAD trial.
Banerjee S; Farina N; Henderson C; High J; Stirling S; Shepstone L; Fountain J; Ballard C; Bentham P; Burns A; Fox C; Francis P; Howard R; Knapp M; Leroi I; Livingston G; Nilforooshan R; Nurock S; O'Brien J; Price A; Thomas AJ; Swart AM; Telling T; Tabet N
Health Technol Assess; 2023 Oct; 27(23):1-108. PubMed ID: 37929672
[TBL] [Abstract][Full Text] [Related]
8. Agitation and aggression in people living with dementia and mild cognitive impairment in shared-housing arrangements - validation of a German version of the Cohen-Mansfield Agitation Inventory-Short Form (CMAI-SF).
Kratzer A; Scheel-Barteit J; Altona J; Wolf-Ostermann K; Graessel E; Donath C
Health Qual Life Outcomes; 2023 May; 21(1):51. PubMed ID: 37248478
[TBL] [Abstract][Full Text] [Related]
9. Distinctive effects between cognitive stimulation and reminiscence therapy on cognitive function and quality of life for different types of behavioural problems in dementia.
Lin HC; Yang YP; Cheng WY; Wang JJ
Scand J Caring Sci; 2018 Jun; 32(2):594-602. PubMed ID: 28881430
[TBL] [Abstract][Full Text] [Related]
10. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
[TBL] [Abstract][Full Text] [Related]
11. Memantine for dementia.
McShane R; Westby MJ; Roberts E; Minakaran N; Schneider L; Farrimond LE; Maayan N; Ware J; Debarros J
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD003154. PubMed ID: 30891742
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of reminiscence therapy in reducing agitation and depression and improving quality of life and cognition in long-term care residents with dementia: A systematic review and meta-analysis.
Thomas JM; Sezgin D
Geriatr Nurs; 2021; 42(6):1497-1506. PubMed ID: 34735996
[TBL] [Abstract][Full Text] [Related]
13. Antidepressants for agitation and psychosis in dementia.
Seitz DP; Adunuri N; Gill SS; Gruneir A; Herrmann N; Rochon P
Cochrane Database Syst Rev; 2011 Feb; (2):CD008191. PubMed ID: 21328305
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the Cohen-Mansfield agitation inventory with the CERAD behavioral rating scale for dementia in community-dwelling persons with Alzheimer's disease.
Weiner MF; Koss E; Patterson M; Jin S; Teri L; Thomas R; Thal LJ; Whitehouse P
J Psychiatr Res; 1998; 32(6):347-51. PubMed ID: 9844950
[TBL] [Abstract][Full Text] [Related]
15. Randomized Placebo-Controlled Trial of Nabilone for Agitation in Alzheimer's Disease.
Herrmann N; Ruthirakuhan M; Gallagher D; Verhoeff NPLG; Kiss A; Black SE; Lanctôt KL
Am J Geriatr Psychiatry; 2019 Nov; 27(11):1161-1173. PubMed ID: 31182351
[TBL] [Abstract][Full Text] [Related]
16. Dementia Care Mapping™ to reduce agitation in care home residents with dementia: the EPIC cluster RCT.
Surr CA; Holloway I; Walwyn RE; Griffiths AW; Meads D; Kelley R; Martin A; McLellan V; Ballard C; Fossey J; Burnley N; Chenoweth L; Creese B; Downs M; Garrod L; Graham EH; Lilley-Kelley A; McDermid J; Millard H; Perfect D; Robinson L; Robinson O; Shoesmith E; Siddiqi N; Stokes G; Wallace D; Farrin AJ
Health Technol Assess; 2020 Mar; 24(16):1-172. PubMed ID: 32216870
[TBL] [Abstract][Full Text] [Related]
17. A double-blind randomized placebo-controlled withdrawal trial comparing memantine and antipsychotics for the long-term treatment of function and neuropsychiatric symptoms in people with Alzheimer's disease (MAIN-AD).
Ballard C; Thomas A; Gerry S; Yu LM; Aarsland D; Merritt C; Corbett A; Davison C; Sharma N; Khan Z; Creese B; Loughlin P; Bannister C; Burns A; Win SN; Walker Z;
J Am Med Dir Assoc; 2015 Apr; 16(4):316-22. PubMed ID: 25523285
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of memantine for agitation in Alzheimer's dementia: a randomised double-blind placebo controlled trial.
Fox C; Crugel M; Maidment I; Auestad BH; Coulton S; Treloar A; Ballard C; Boustani M; Katona C; Livingston G
PLoS One; 2012; 7(5):e35185. PubMed ID: 22567095
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
